摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-氟-2-(1-(5-氟-6-(4-甲氧基苯氧基)-嘧啶-4-基)哌啶-4-氧基)嘧啶-4-胺 | 1033833-23-6

中文名称
5-氟-2-(1-(5-氟-6-(4-甲氧基苯氧基)-嘧啶-4-基)哌啶-4-氧基)嘧啶-4-胺
中文别名
——
英文名称
5-fluoro-2-(1-(5-fluoro-6-(4-methoxyphenoxy)-pyrimidin-4-yl)piperidin-4-yloxy)pyrimidin-4-amine
英文别名
5-Fluoro-2-(1-(5-fluoro-6-(4-methoxyphenoxy)pyrimidin-4-yl)piperidin-4-yloxy)pyrimidin-4-amine;5-fluoro-2-[1-[5-fluoro-6-(4-methoxyphenoxy)pyrimidin-4-yl]piperidin-4-yl]oxypyrimidin-4-amine
5-氟-2-(1-(5-氟-6-(4-甲氧基苯氧基)-嘧啶-4-基)哌啶-4-氧基)嘧啶-4-胺化学式
CAS
1033833-23-6
化学式
C20H20F2N6O3
mdl
——
分子量
430.414
InChiKey
UDVBFHPKSIMPAJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    31
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    109
  • 氢给体数:
    1
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • O-LINKED PYRIMIDIN-4-AMINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE TO TREAT CANCER
    申请人:Augeri David J.
    公开号:US20080146571A1
    公开(公告)日:2008-06-19
    O-linked pyrimidin-4-amine-based compounds, pharmaceutical compositions comprising them, and methods of their use are described. Particular compounds of the invention are of formula I:
    O-连接的嘧啶-4-胺基化合物,包括它们的药物组合物以及它们的使用方法。本发明的特定化合物为公式I:
  • 2-(PIPERIDIN-4-YL0XY)PYRIMIDIN-4-AMINE DERIVATIVES AS DEOXYCYTIDINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER
    申请人:Lexicon Pharmaceuticals, Inc.
    公开号:EP2104672A2
    公开(公告)日:2009-09-30
  • US8093246B2
    申请人:——
    公开号:US8093246B2
    公开(公告)日:2012-01-10
  • [EN] O-LINKED PYRIMIDIN-4-AMINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE<br/>[FR] COMPOSÉS À BASE DE PYRIMIDINE-4-AMINE À LIAISON O, COMPOSITIONS LES CONTENANT ET PROCÉDÉS D'UTILISATION DE CEUX-CI
    申请人:LEXICON PHARMACEUTICALS INC
    公开号:WO2008076779A2
    公开(公告)日:2008-06-26
    [EN] O-linked pyrimidin-4-amine-based compounds, pharmaceutical compositions comprising them, and methods of their use are described. Particular compounds of the invention are of formula (I).
    [FR] L'invention concerne des composés à base de pyrimidine-4-amine à liaison O, des compositions pharmaceutiques les contenant et des procédés d'utilisation de ceux-ci. Des composés particuliers de l'invention sont représentés par la formule (I).
  • 5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase
    作者:James E. Tarver、Theodore C. Jessop、Marianne Carlsen、David J. Augeri、Qinghong Fu、Jason P. Healy、Alexander Heim-Riether、Amy Xu、Jerry A. Taylor、Min Shen、Philip E. Keyes、S. David Kimball、Xuan-Chuan Yu、Maricar Miranda、Qingyun Liu、Jonathan C. Swaffield、Amr Nouraldeen、Alan G.E. Wilson、Rick Finch、Kanchan Jhaver、Ann Marie DiGeorge Foushee、Steve Anderson、Tamas Oravecz、Kenneth G. Carson
    DOI:10.1016/j.bmcl.2009.09.082
    日期:2009.12
    A series of potent piperidine-linked cytosine derivatives were prepared as inhibitors of deoxycytidine kinase (dCK). Compound 9h was discovered to be a potent inhibitor of dCK and shows a good combination of cellular potency and pharmacokinetic parameters. Compound 9h blocks the incorporation of radiolabeled cytosine into mouse T-cells in vitro, as well as in vivo in mice following a T-cell challenge. (C) 2009 Published by Elsevier Ltd.
查看更多